TEVA PHARMACEUTICAL INDUSTRIES LIMITED Interest Expense
TEVA PHARMACEUTICAL INDUSTRIES LIMITED (TEVJF) reported Interest Expense of $916.00 million for the 12-month period ending 2025-12-31, per its 10-K filed 2026-02-03.
Financial Statements › Expense Statement › Interest Expense
us-gaap:InterestExpense · last filed 2026-02-03
- TEVA PHARMACEUTICAL INDUSTRIES LIMITED interest expense for fiscal 2025 was $916.00M, a 8.58% decline from fiscal 2024.
- TEVA PHARMACEUTICAL INDUSTRIES LIMITED interest expense for fiscal 2024 was $1.00B, a 2.62% decline from fiscal 2023.
- TEVA PHARMACEUTICAL INDUSTRIES LIMITED interest expense for fiscal 2023 was $1.03B, a 10.65% increase from fiscal 2022.
- TEVA PHARMACEUTICAL INDUSTRIES LIMITED interest expense for fiscal 2022 was $930.00M, a 4.38% increase from fiscal 2021.
| Period end | Interest Expense 12 month | Interest Expense 12 month as first filed |
|---|---|---|
| 2025-12-31 | $916.00M 10-K · filed 2026-02-03 | |
| 2024-12-31 | $1.00B 10-K · filed 2026-02-03 | |
| 2023-12-31 | $1.03B 10-K · filed 2026-02-03 | |
| 2022-12-31 | $930.00M 10-K · filed 2025-02-05 | |
| 2021-12-31 | $891.00M 10-K · filed 2024-02-12 | |
| 2020-12-31 | $901.00M 10-K · filed 2023-02-10 | $963.00M 10-K · filed 2021-02-10 |
| 2019-12-31 | $822.00M 10-K · filed 2022-02-09 | $881.00M 10-K · filed 2020-02-21 |
| 2018-12-31 | $920.00M 10-K · filed 2021-02-10 | |
| 2017-12-31 | $875.00M 10-K · filed 2020-02-21 | |
| 2016-12-31 | $546.00M 10-K · filed 2019-02-19 | |
| 2015-12-31 | $270.00M 10-K · filed 2018-02-12 | |
| 2014-12-31 | $300.00M 20-F · filed 2017-02-15 | |
| 2013-12-31 | $314.00M 20-F · filed 2016-02-11 | |
| 2012-12-31 | $355.00M 20-F · filed 2015-02-09 | |
| 2011-12-31 | $234.00M 20-F · filed 2014-02-10 | |
| 2010-12-31 | $202.00M 20-F · filed 2013-02-12 | |
| 2009-12-31 | $230.00M 20-F · filed 2012-02-17 | |
| 2008-12-31 | $201.00M 20-F · filed 2011-02-15 |